Pfizer
Search results
Our purpose. We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
Advanced technology is increasing the chances of improving outcomes for cancer patients. ‘Global health progress is vital for millions of lives, but it isn’t going fast enough. Here’s what we need to do to get things back on track’. ‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics.
A new era for human health. In India, we have a legacy of nearly 100 years. With our new purpose, strategy and culture, we will move #AheadTogether continuing our legacy in General Medicines, our leadership in the Vaccines self-pay market and introduce innovative offerings through our Specialty medicines. Purpose, strategy and culture. We Are GSK.
19 March 2024. 42nd annual JP Morgan Healthcare Conference. Listen to the webcast. Access all speeches and presentations. 09 January 2024. Getting ahead of Respiratory Diseases with GSK management. Watch the recording. Access all speeches and presentations. 30 November 2023.
GSK acquires full rights to develop, manufacture and commercialise globally mRNA candidate vaccines for influenza and COVID-19. Download (PDF, 144.1KB) 28 June 2024 Statement: Zantac (ranitidine) litigation – Gross case. GSK has reached a confidential settlement with Martin Gross resolving the case he filed. Download (PDF, 176.0KB) 26 June 2024
To pioneer HIV treatments in 1980 and leaders in HIV innovation. 1st. To produce a new medicine for Lupus in 50+ years. 1st. Investigational medicines in our oncology pipeline. 11. Patients reached with our general medicines over the next ten years. 700m. Medicines in our portfolio.
Registered office: GSK House, Dr. Annie Besant Road, Worli, Mumbai 400030 > Modern Slavery Act Statement 2021 (PDF - 211.0KB) GSK websites
